Log in

OTCMKTS:ASNB - AdvanSource Biomaterials Corpration Stock Price, Forecast & News

$0.18
0.00 (0.00 %)
(As of 01/19/2020 12:32 PM ET)
Today's Range
$0.17
Now: $0.18
$0.18
50-Day Range
$0.15
MA: $0.16
$0.18
52-Week Range
$0.05
Now: $0.18
$0.19
Volume325,700 shs
Average Volume35,483 shs
Market Capitalization$3.87 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.31
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ASNB
CUSIPN/A
Phone424-256-8560

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.35 million
Cash Flow$0.02 per share
Book Value($0.01) per share

Profitability

Net Income$330,000.00

Miscellaneous

Employees11
Market Cap$3.87 million
Next Earnings Date2/12/2020 (Estimated)
OptionableNot Optionable

Receive ASNB News and Ratings via Email

Sign-up to receive the latest news and ratings for ASNB and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


A brand-new technology - code named "Halo-Fi" - could kill off your overpriced cable company for good... beaming lightning-fast internet to your home for an estimated $7 a month.

This is undoubtedly the beginning of the end for "Big 3" internet providers.

Forward-thinking investors in Halo-Fi are lining up to get rich before January 30th.

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) Frequently Asked Questions

What is AdvanSource Biomaterials Corpration's stock symbol?

AdvanSource Biomaterials Corpration trades on the OTCMKTS under the ticker symbol "ASNB."

How were AdvanSource Biomaterials Corpration's earnings last quarter?

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) posted its quarterly earnings data on Thursday, October, 16th. The company reported $0.31 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.02. AdvanSource Biomaterials Corpration had a net margin of 13.71% and a negative return on equity of 293.13%. During the same period last year, the business posted $0.27 EPS. View AdvanSource Biomaterials Corpration's Earnings History.

When is AdvanSource Biomaterials Corpration's next earnings date?

AdvanSource Biomaterials Corpration is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for AdvanSource Biomaterials Corpration.

Has AdvanSource Biomaterials Corpration been receiving favorable news coverage?

Media headlines about ASNB stock have trended negative on Sunday, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. AdvanSource Biomaterials Corpration earned a news impact score of -2.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for AdvanSource Biomaterials Corpration.

Who are some of AdvanSource Biomaterials Corpration's key competitors?

What other stocks do shareholders of AdvanSource Biomaterials Corpration own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AdvanSource Biomaterials Corpration investors own include Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), Agile Therapeutics (AGRX), FuelCell Energy (FCEL), Frequency Therapeutics (FREQ), Interpace Diagnostics Group (IDXG), Achillion Pharmaceuticals (ACHN), Sphere 3D (ANY) and BioScrip (BIOS).

Who are AdvanSource Biomaterials Corpration's key executives?

AdvanSource Biomaterials Corpration's management team includes the folowing people:
  • Michael F. Adams, President & Chief Executive Officer
  • Khristine L. Carroll, Senior Vice President-Commercial Operations

How do I buy shares of AdvanSource Biomaterials Corpration?

Shares of ASNB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is AdvanSource Biomaterials Corpration's stock price today?

One share of ASNB stock can currently be purchased for approximately $0.18.

How big of a company is AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration has a market capitalization of $3.87 million and generates $3.35 million in revenue each year. AdvanSource Biomaterials Corpration employs 11 workers across the globe.View Additional Information About AdvanSource Biomaterials Corpration.

What is AdvanSource Biomaterials Corpration's official website?

The official website for AdvanSource Biomaterials Corpration is http://www.advbiomaterials.com/.

How can I contact AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration's mailing address is 229 ANDOVER STREET, WILMINGTON MA, 01887. The company can be reached via phone at 424-256-8560 or via email at [email protected]


MarketBeat Community Rating for AdvanSource Biomaterials Corpration (OTCMKTS ASNB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  157
MarketBeat's community ratings are surveys of what our community members think about AdvanSource Biomaterials Corpration and other stocks. Vote "Outperform" if you believe ASNB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ASNB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel